A genetically engineered single-chain antibody strain expressing resistance to citreogreen penicillin and its application
A yellow-green penicillin and single-chain antibody technology, applied in microorganism-based methods, anti-fungal/algal/lichen immunoglobulins, instruments, etc., can solve the problems of CIT toxins that have not been reported.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0019] Example 1 Preparation and identification of the single-chain antibody of the present invention.
[0020] 1. Preparation of citreoviridin artificial complete antigen
[0021] In this experiment, citreoviridin (CIT) was cross-linked with carrier proteins BSA and KLH to form immunogenic artificial complete antigens CIT-BSA and CIT-KLH. The entire cross-linking process is carried out in two steps. In the first step, the hydroxyl group on the 3-position of the citreoviridin molecule is transformed into a carboxyl group by the succinic anhydride method; The amino groups are linked together through dehydration condensation. Specific steps are as follows:
[0022] (1) Weigh 60 mg of succinic anhydride powder and dissolve it in 500 μL of anhydrous pyridine, add an equal amount of 1 mol / L DMAP at the same time, preheat in a 65°C oven for 30-60 min, and activate succinic anhydride.
[0023] (2) Add the succinic anhydride solution directly to 1 mg of CIT solid, make it fully dis...
PUM
| Property | Measurement | Unit |
|---|---|---|
| affinity | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


